Literature DB >> 16000880

Identification of a putative transactivation domain in human Nanog.

Jong-Hyun Oh1, Hyun-Jin Do, Heung-Mo Yang, Shin-Yong Moon, Kwang-Yul Cha, Hyung-Min Chung, Jae-Hwan Kim.   

Abstract

Nanog is a newly identified divergent homeodomain protein that directs the infinite propagation and sustains the pluripotency of embryonic stem cells. It has been reported that murine Nanog has two potent transactivation domains in N-terminal and C-terminal regions. Human Nanog (hNanog) polypeptide shares about 58% and 87% identity to the open reading frame and homeodomain of murine Nanog, respectively. However, the functional domains and molecular mechanisms of hNanog are poorly understood. In this study, for the first time, we presented that only C-terminus of hNanog contains a potent transactivation domain. Based on the amino acid sequences of homeobox domain, we roughly divided hNanog open reading frame into the three regions such as N-terminal, homeodomain and C-terminal regions and constructed either the fusion proteins between hNanog individual and Gal4 DNA binding domain or the context of native hNanog protein. Reporter assays by using reporter plamid containing Gal4 or Nanog binding site revealed that the only C-terminal region exhibited the significant fold induction of transactivation. However, interestingly, there was no significant activation through N-terminal region unlike murine Nanog, suggesting that C-terminal region may have more critical roles in the transcriptional activation of target genes. Taken together, the finding of a putative transactivation domain in hNanog may contribute to the further understanding of molecular mechanism on the regulation of downstream genes involved in self-renewal and pluripotency of human stem cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16000880     DOI: 10.1038/emm.2005.33

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  10 in total

1.  Alternative splicing produces Nanog protein variants with different capacities for self-renewal and pluripotency in embryonic stem cells.

Authors:  Satyabrata Das; Snehalata Jena; Dana N Levasseur
Journal:  J Biol Chem       Date:  2011-10-03       Impact factor: 5.157

2.  Characterization of Danio rerio Nanog and functional comparison to Xenopus Vents.

Authors:  Maximilian Schuff; Doreen Siegel; Melanie Philipp; Karin Bundschu; Nicole Heymann; Cornelia Donow; Walter Knöchel
Journal:  Stem Cells Dev       Date:  2011-10-03       Impact factor: 3.272

Review 3.  NANOG: a promising target for digestive malignant tumors.

Authors:  Ai-Xi Sun; Chang-Jiang Liu; Zi-Qin Sun; Zhi Wei
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Nanog signaling in cancer promotes stem-like phenotype and immune evasion.

Authors:  Kyung Hee Noh; Bo Wook Kim; Kwon-Ho Song; Hanbyoul Cho; Young-Ho Lee; Jin Hee Kim; Joon-Yong Chung; Jae-Hoon Kim; Stephen M Hewitt; Seung-Yong Seong; Chih-Ping Mao; T-C Wu; Tae Woo Kim
Journal:  J Clin Invest       Date:  2012-10-24       Impact factor: 14.808

5.  Requirement of Nanog dimerization for stem cell self-renewal and pluripotency.

Authors:  Jianlong Wang; Dana N Levasseur; Stuart H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-24       Impact factor: 11.205

6.  Transcriptional properties of human NANOG1 and NANOG2 in acute leukemic cells.

Authors:  Irina Eberle; Birgit Pless; Miriam Braun; Theo Dingermann; Rolf Marschalek
Journal:  Nucleic Acids Res       Date:  2010-04-28       Impact factor: 16.971

7.  A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A.

Authors:  Xin Zhang; Irina Neganova; Stefan Przyborski; Chunbo Yang; Michael Cooke; Stuart P Atkinson; George Anyfantis; Stefan Fenyk; W Nicol Keith; Stacey F Hoare; Owen Hughes; Tom Strachan; Miodrag Stojkovic; Philip W Hinds; Lyle Armstrong; Majlinda Lako
Journal:  J Cell Biol       Date:  2009-01-12       Impact factor: 10.539

Review 8.  Targeting cancer stem cells: emerging role of Nanog transcription factor.

Authors:  Mong-Lien Wang; Shih-Hwa Chiou; Cheng-Wen Wu
Journal:  Onco Targets Ther       Date:  2013-09-04       Impact factor: 4.147

9.  Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species.

Authors:  Bigang Liu; Mark D Badeaux; Grace Choy; Dhyan Chandra; Irvin Shen; Collene R Jeter; Kiera Rycaj; Chia-Fang Lee; Maria D Person; Can Liu; Yueping Chen; Jianjun Shen; Sung Yun Jung; Jun Qin; Dean G Tang
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

10.  The pluripotency factor Nanog regulates pericentromeric heterochromatin organization in mouse embryonic stem cells.

Authors:  Clara Lopes Novo; Calvin Tang; Kashif Ahmed; Ugljesa Djuric; Eden Fussner; Nicholas P Mullin; Natasha P Morgan; Jasvinder Hayre; Arnold R Sienerth; Sarah Elderkin; Ryuichi Nishinakamura; Ian Chambers; James Ellis; David P Bazett-Jones; Peter J Rugg-Gunn
Journal:  Genes Dev       Date:  2016-04-28       Impact factor: 11.361

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.